Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
for Breast Atypical Hyperplasia
4 locations incl. Duarte
Sponsor: National Cancer Institute (NCI)
Sex: Female·Age: 35+
Code: NCT05941520·Phase 2·Recruiting